Trademark: 97459047
Status Date
Tuesday, November 28, 2023
Filing Date
Wednesday, June 15, 2022
Published for Opposition
Tuesday, October 3, 2023
5 Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of diabetes; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of diabetes
42 Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development
VCTX 211
VCTX TWO ONE ONE; VCTX TWO HUNDRED ELEVEN
Nov 28, 2023
Noa E-Mailed - Sou Required From Applicant
Oct 3, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 3, 2023
Published For Opposition
Sep 13, 2023
Notification Of Notice Of Publication E-Mailed
Aug 25, 2023
Approved For Pub - Principal Register
Jul 27, 2023
Teas/Email Correspondence Entered
Jul 27, 2023
Correspondence Received In Law Office
Jul 27, 2023
Assigned To Lie
Jul 3, 2023
Assigned To Examiner
Mar 20, 2023
Teas Response To Office Action Received
Feb 10, 2023
Notification Of Non-Final Action E-Mailed
Feb 10, 2023
Non-Final Action E-Mailed
Feb 10, 2023
Non-Final Action Written
Feb 7, 2023
Assigned To Examiner
Jun 28, 2022
New Application Office Supplied Data Entered
Jun 18, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
